首页> 外文期刊>International journal of immunogenetics >A novel HLA-B*40 sequence--B*40:92.
【24h】

A novel HLA-B*40 sequence--B*40:92.

机译:一种新颖的HLA-B * 40序列-B * 40:92。

获取原文
获取原文并翻译 | 示例
           

摘要

A new allele, HLA-B*40:92, was identified in a north-western European subject during polymerase chain reaction using sequence-specific priming (PCR-SSP)-based typing of haematopoietic stem cell (HSC) donors. B*40:92 differs from B*40:01:01 by six nucleotides at positions 559, 560, 603, 605, 610 and 618 in exon 3 which represents a substitution motif of at least 60 nucleotides. This motif, which occurs in numerous HLA alleles including the relatively high frequency B*15 and B*35 allele families, encode four amino acid changes at positions 163 (glutamic acid > leucine), 177 (aspartic acid > glutamic acid), 178 (lysine > threonine), 180 (glutamic acid > glutamine) and a silent substitution, conserved alanine, at codon 182. Thus, it is likely that HLA-B*40:92 occurred following a gene conversion-like or interallelic recombination event involving B*40:01:01 and probably a B*15 or more likely a B*35 family allele. HLA-B*40:92 was found on a haplotype with HLA-A*02:01, B*40:92, C*03:04, DRB1*13:02, DRB3*03:01, DQA1*01:02, DQB1*06:04, DPA1*02:02, DPB1*05:01. Tests on 69 selected B40 and B35 antisera and Lambda Monoclonal Trays show that B*40:92 encodes a 'short' B40/B60 serological specificity which displays some HLA-B35 reactivity. The HLA-B40 and HLA-B35 motifs (possible epitopes) responsible for this serological reactivity were identified. This single example of HLA- B*40:92 was found in 56,823 consecutive HLA PCR-SSP typed HSC donors indicating a carriage frequency of 0.00176% (allele frequency 0.00001) in blood donors resident in Wales. An Epstein-Barr virus transformed B-cell line from the HLA-B*40:92 donor is available.
机译:在西北欧洲的一个受试者中,使用基于序列特异性引物(PCR-SSP)的造血干细胞(HSC)供体分型,在聚合酶链反应中鉴定了一个新的等位基因HLA-B * 40:92。 B * 40:92与B * 40:01:01在外显子3的559、560、603、605、610和618位的六个核苷酸不同,它代表至少60个核苷酸的取代基序。该基序出现在许多HLA等位基因中,包括相对较高频率的B * 15和B * 35等位基因家族,在163位(谷氨酸>亮氨酸),177(天冬氨酸>谷氨酸),178(赖氨酸>苏氨酸),180(谷氨酸>谷氨酰胺)和182位密码子的沉默取代(保守的丙氨酸)。因此,很可能在涉及B的基因转化或等位基因重组事件之后发生了HLA-B * 40:92 * 40:01:01,可能是B * 15或更可能是B * 35家族等位基因。在具有HLA-A * 02:01,B * 40:92,C * 03:04,DRB1 * 13:02,DRB3 * 03:01,DQA1 * 01:02的单倍型上发现了HLA-B * 40:92 ,DQB1 * 06:04,DPA1 * 02:02,DPB1 * 05:01。对69个选定的B40和B35抗血清和Lambda单克隆托盘进行的测试表明,B * 40:92编码“短” B40 / B60血清学特异性,显示出某些HLA-B35反应性。确定了负责这种血清反应性的HLA-B40和HLA-B35基序(可能的表位)。在56823个连续的HLA PCR-SSP型HSC供体中发现了HLA-B * 40:92的单个例子,表明在威尔士居住的献血者中携带频率为0.00176%(等位基因频率为0.00001)。可从HLA-B * 40:92供体获得爱泼斯坦-巴尔病毒转化的B细胞系。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号